Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 25

Sort by

Sort Order Select

Journal Articles

Direct oral anticoagulants for cancer-associated venous thromboembolism: a systematic review and meta-analysis

Frits I. Mulder, Floris T. M. Bosch, Annie M. Young, Andrea Marshall, Robert D. McBane, II, Tyler J. Zemla, Marc Carrier, Pieter Willem Kamphuisen, Patrick M. M. Bossuyt, Harry R. Büller, Jeffrey I. Weitz, Saskia Middeldorp, Nick van Es

Blood (2020) 136 (12): 1433–1441.

https://doi.org/10.1182/blood.2020005819

Published: 2020

Includes: Supplemental data

Journal Articles

Meta-Analysis of Long-Term Risk of Recurrent Venous Thromboembolism after Stopping Anticoagulation in Men and Women with First Unprovoked Venous Thromboembolism

Blood (2018) 132 (Supplement 1): 2527.

https://doi.org/10.1182/blood-2018-99-113589

Published: 2018

Journal Articles

A Randomized, Open-Label, Blinded Outcome Assessment Trial Evaluating the Efficacy and Safety of LMWH/Edoxaban Versus Dalteparin for Venous Thromboembolism Associated with Cancer: Hokusai VTE-Cancer Study

Gary E. Raskob, PhD, Nick Van Es, MD, Peter Verhamme, MD PhD, Marc Carrier, MD, Marcello Di Nisio, MD, David A. Garcia, MD, Michael A. Grosso, MD, Ajay K. Kakkar, MBBS, Michael J. Kovacs, MD, Michele F. Mercuri, MD PhD FAHA, Guy Meyer, MD, Annelise Segers, MD, Minggao Shi, PhD, Tzu-Fei Wang, MD, Erik Yeo, MD FACP, FRCPC, George Zhang, PhD, Jeffrey I. Zwicker, MD, Jeffrey I. Weitz, MD, Harry R. Büller, MD PhD

Blood (2017) 130 (Supplement 1): LBA-6.

https://doi.org/10.1182/blood.V130.Suppl_1.LBA-6.LBA-6

Published: 2017

Journal Articles

The Performance of the Original and Simplified Wells Scores in Combination with Age-Adjusted D-Dimer Testing in the Diagnostic Management of Pulmonary Embolism

Noémie Kraaijpoel, MSc, Nick van Es, MD, Harry R Büller, MD PhD, Frederikus A Klok, MD PhD, Menno V Huisman, Paul L den Exter, MD PhD, Javier Galipienzo, MD PhD, Saskia Middeldorp, MD PhD, Patrick M Bossuyt, PhD

Blood (2016) 128 (22): 2569.

https://doi.org/10.1182/blood.V128.22.2569.2569

Published: 2016

Journal Articles

Clinical Impact and Course of Anticoagulant-Related Major Bleeding in Cancer Patients

Noémie Kraaijpoel, MSc, Nick van Es, MD, Suzanne M Bleker, MD, Marjolein P Brekelmans, MD, Elise S Eerenberg, MD, Saskia Middeldorp, MD PhD Professor of MDcine, Alexander T Cohen, MBBS MSc MD, Harry R Büller, MD PhD

Blood (2016) 128 (22): 2611.

https://doi.org/10.1182/blood.V128.22.2611.2611

Published: 2016

Journal Articles

A New Microparticle Coagulant Activity Assay to Predict Venous Thromboembolism in Patients with Pancreatic Cancer

Nick van Es, MD, Suzanne Bleker, MD, Ankie Kleinjan, MDPhD, Rene Berckmans, PhD, J W Wilmink, MDPhD, Rienk Nieuwland, PhD, Saskia Middeldorp, MD PhD, Harry R Büller, MD PhD

Blood (2014) 124 (21): 4250.

https://doi.org/10.1182/blood.V124.21.4250.4250

Published: 2014

Journal Articles

Time in Therapeutic Range (TTR) and Relative Efficacy and Safety of Treatment with Apixaban or Enoxaparin/Warfarin for Acute Symptomatic Venous Thromboembolism: An Analysis of the Amplify Trial Data

Alexander Cohen, MD, Alexander S. Gallus, MD, Giancarlo Agnelli, MD, Harry R Buller, MD PhD, Raphael Pak, PhD, Anthony R. Porcari, PhD PharmD, Gary E. Raskob, PhD, Jeffrey I. Weitz, MDFRCPC, Takaharu Yamabe, PhD

Blood (2014) 124 (21): 1543.

https://doi.org/10.1182/blood.V124.21.1543.1543

Published: 2014

Journal Articles

Unsuspected Pulmonary Embolism in Cancer Patients: A Multicenter, International, Prospective, Observational Study

Suzanne Bleker, MD, Nick van Es, MD, Ankie Kleinjan, MD PhD, Harry R. Büller, MD PhD, Saskia Middeldorp, MD PhD, Marcello Dinisio, MD PhD

Blood (2014) 124 (21): 1546.

https://doi.org/10.1182/blood.V124.21.1546.1546

Published: 2014

Journal Articles

Direct oral anticoagulants compared with vitamin K antagonists for acute venous thromboembolism: evidence from phase 3 trials

Nick van Es, Michiel Coppens, Sam Schulman, Saskia Middeldorp, Harry R. Büller

Blood (2014) 124 (12): 1968–1975.

https://doi.org/10.1182/blood-2014-04-571232

Published: 2014

Includes: Supplemental data

Journal Articles

Risk profile and clinical outcome of symptomatic subsegmental acute pulmonary embolism

Paul L. den Exter, Josien van Es, Frederikus A. Klok, Lucia J. Kroft, Marieke J. H. A. Kruip, Pieter Willem Kamphuisen, Harry R. Büller, Menno V. Huisman

Blood (2013) 122 (7): 1144–1149.

https://doi.org/10.1182/blood-2013-04-497545

Published: 2013

Journal Articles

Thrombotic risk during oral contraceptive use and pregnancy in women with factor V Leiden or prothrombin mutation: a rational approach to contraception

Elizabeth F. W. van Vlijmen, Nic J. G. M. Veeger, Saskia Middeldorp, Karly Hamulyák, Martin H. Prins, Harry R. Büller, Karina Meijer

Blood (2011) 118 (8): 2055–2061.

https://doi.org/10.1182/blood-2011-03-345678

Published: 2011

Journal Articles

Increasing levels of free thyroxine as a risk factor for a first venous thrombosis: a case-control study

Bregje van Zaane, Alessandro Squizzato, Roeland Huijgen, Anton P. van Zanten, Eric Fliers, Suzanne C. Cannegieter, Harry R. Büller, Victor E. A. Gerdes, Dees P. M. Brandjes

Blood (2010) 115 (22): 4344–4349.

https://doi.org/10.1182/blood-2009-11-253724

Published: 2010

Journal Articles

Aspirin and Aspirin Combined with Low-Molecular-Weight Heparin in Women with Unexplained Recurrent Miscarriage: a Randomized Controlled Multicenter Trial (ALIFE Study).

Stef P. Kaandorp, MD, Mariëtte Goddijn, MD, PhD, Joris A.M. van der Post, MD, PhD, Barbara A. Hutten, PhD, Harold R. Verhoeve, MD, Karly Hamulyak, MD, PhD, Ben-Willem Mol, MD, PhD, Nienke Folkeringa, MD, PhD, Marleen Nahuis, MD, Dimitri Papatsonis, MD, PhD, Harry R. Buller, MD, PhD, Fulco van der Veen, MD, PhD, Saskia Middeldorp, MD, PhD

Blood (2009) 114 (22): 488.

https://doi.org/10.1182/blood.V114.22.488.488

Published: 2009

Journal Articles

A lower risk of recurrent venous thrombosis in women compared with men is explained by sex-specific risk factors at time of first venous thrombosis in thrombophilic families

Willem M. Lijfering, Nic J. G. M. Veeger, Saskia Middeldorp, Karly Hamulyák, Martin H. Prins, Harry R. Büller, Jan van der Meer

Blood (2009) 114 (10): 2031–2036.

https://doi.org/10.1182/blood-2009-04-215418

Published: 2009

Journal Articles

Endogenous activated protein C limits cancer cell extravasation through sphingosine-1-phosphate receptor 1–mediated vascular endothelial barrier enhancement

Geerte L. Van Sluis, Tatjana M.H. Niers, Charles T. Esmon, Wikky Tigchelaar, Dick J. Richel, Harry R. Buller, Cornelis J.F. Van Noorden, C. Arnold Spek

Blood (2009) 114 (9): 1968–1973.

https://doi.org/10.1182/blood-2009-04-217679

Published: 2009

Journal Articles

Selective testing for thrombophilia in patients with first venous thrombosis: results from a retrospective family cohort study on absolute thrombotic risk for currently known thrombophilic defects in 2479 relatives

Willem M. Lijfering, Jan-Leendert P. Brouwer, Nic J. G. M. Veeger, Ivan Bank, Michiel Coppens, Saskia Middeldorp, Karly Hamulyák, Martin H. Prins, Harry R. Büller, Jan van der Meer

Blood (2009) 113 (21): 5314–5322.

https://doi.org/10.1182/blood-2008-10-184879

Published: 2009

Journal Articles

Hyperthyroidism as a Risk Factor for Venous Thromboembolism: A Case-Control Study

Bregje van Zaane, MD, Alessandro Squizzato, MD, Roeland Huijgen, MD, Anton P van Zanten, Eric Fliers, MD, PhD, Harry R Buller, MD, PhD, Victor E.A. Gerdes, MD, PhD, Dees P.M. Brandjes, MD, PhD

Blood (2008) 112 (11): 5350.

https://doi.org/10.1182/blood.V112.11.5350.5350

Published: 2008

Journal Articles

A dose-ranging study evaluating once-daily oral administration of the factor Xa inhibitor rivaroxaban in the treatment of patients with acute symptomatic deep vein thrombosis: the Einstein–DVT Dose-Ranging Study

Harry R. Buller, Anthonie W. A. Lensing, Martin H. Prins, Giancarlo Agnelli, Alexander Cohen, Alexander S. Gallus, Frank Misselwitz, Gary Raskob, Sebastian Schellong, Annelise Segers

Blood (2008) 112 (6): 2242–2247.

https://doi.org/10.1182/blood-2008-05-160143

Published: 2008

Includes: Supplemental data

Journal Articles

Bleeding in patients receiving vitamin K antagonists who would have been excluded from trials on which the indication for anticoagulation was based

Marcel Levi, G. Kees Hovingh, Suzanne C. Cannegieter, Marinus Vermeulen, Harry R. Büller, Frits R. Rosendaal

Blood (2008) 111 (9): 4471–4476.

https://doi.org/10.1182/blood-2007-11-123711

Published: 2008

Journal Articles

No Difference in Risk of Recurrent Venous Thrombosis between Men and Women. Results from a Family Cohort Study in 3356 Subjects.

Willem M. Lijfering, MD, Michiel Coppens, MD, Nic J.G.M. Veeger, MSc, Saskia Middeldorp, MD, PhD, Karly Hamulyak, MD, PhD, Martin H. Prins, MD, Phd, Harry R. Buller, MD, PhD, Jan van der Meer, Md, PhD

Blood (2007) 110 (11): 130.

https://doi.org/10.1182/blood.V110.11.130.130

Published: 2007

NARROW

Direct oral anticoagulants for cancer-associated venous thromboembolism: a systematic review and meta-analysis

Meta-Analysis of Long-Term Risk of Recurrent Venous Thromboembolism after Stopping Anticoagulation in Men and Women with First Unprovoked Venous Thromboembolism

A Randomized, Open-Label, Blinded Outcome Assessment Trial Evaluating the Efficacy and Safety of LMWH/Edoxaban Versus Dalteparin for Venous Thromboembolism Associated with Cancer: Hokusai VTE-Cancer Study

The Performance of the Original and Simplified Wells Scores in Combination with Age-Adjusted D-Dimer Testing in the Diagnostic Management of Pulmonary Embolism

Clinical Impact and Course of Anticoagulant-Related Major Bleeding in Cancer Patients

A New Microparticle Coagulant Activity Assay to Predict Venous Thromboembolism in Patients with Pancreatic Cancer

Time in Therapeutic Range (TTR) and Relative Efficacy and Safety of Treatment with Apixaban or Enoxaparin/Warfarin for Acute Symptomatic Venous Thromboembolism: An Analysis of the Amplify Trial Data

Unsuspected Pulmonary Embolism in Cancer Patients: A Multicenter, International, Prospective, Observational Study

Direct oral anticoagulants compared with vitamin K antagonists for acute venous thromboembolism: evidence from phase 3 trials

Risk profile and clinical outcome of symptomatic subsegmental acute pulmonary embolism

Thrombotic risk during oral contraceptive use and pregnancy in women with factor V Leiden or prothrombin mutation: a rational approach to contraception

Increasing levels of free thyroxine as a risk factor for a first venous thrombosis: a case-control study

Aspirin and Aspirin Combined with Low-Molecular-Weight Heparin in Women with Unexplained Recurrent Miscarriage: a Randomized Controlled Multicenter Trial (ALIFE Study).

A lower risk of recurrent venous thrombosis in women compared with men is explained by sex-specific risk factors at time of first venous thrombosis in thrombophilic families

Endogenous activated protein C limits cancer cell extravasation through sphingosine-1-phosphate receptor 1–mediated vascular endothelial barrier enhancement

Selective testing for thrombophilia in patients with first venous thrombosis: results from a retrospective family cohort study on absolute thrombotic risk for currently known thrombophilic defects in 2479 relatives

Hyperthyroidism as a Risk Factor for Venous Thromboembolism: A Case-Control Study

A dose-ranging study evaluating once-daily oral administration of the factor Xa inhibitor rivaroxaban in the treatment of patients with acute symptomatic deep vein thrombosis: the Einstein–DVT Dose-Ranging Study

Bleeding in patients receiving vitamin K antagonists who would have been excluded from trials on which the indication for anticoagulation was based

No Difference in Risk of Recurrent Venous Thrombosis between Men and Women. Results from a Family Cohort Study in 3356 Subjects.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only